Literature DB >> 10520445

Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs.

K F Daoud1, C G Jackson, H J Williams.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are often the initial treatment for rheumatoid arthritis. NSAID-induced inhibition of cyclooxygenase-2 (COX2) and cyclooxygenase-1 appears to correlate with clinical efficacy and toxicity, respectively. Newer NSAIDs with greater COX2 selectivity offer the promise of less toxic therapy.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10520445     DOI： 10.1007/bf02944294

Source DB:  PubMed          Journal:  Compr Ther        ISSN： 0098-8243


  6 in total

1.  Autoimmune disease and risk for Parkinson disease: a population-based case-control study.

Authors:  K Rugbjerg; S Friis; B Ritz; E S Schernhammer; L Korbo; J H Olsen
Journal:  Neurology       Date:  2009-09-23       Impact factor: 9.910

2.  Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Authors:  R A Burgos; J L Hancke; J C Bertoglio; V Aguirre; S Arriagada; M Calvo; D D Cáceres
Journal:  Clin Rheumatol       Date:  2009-04-29       Impact factor: 2.980

3.  Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis.

Authors:  Ala'a Ahmed Abu-Ghefreh; Willias Masocha
Journal:  BMC Musculoskelet Disord       Date:  2010-12-01       Impact factor: 2.362

4.  Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors.

Authors:  Subramanian S Parvathy; Willias Masocha
Journal:  Sci Rep       Date:  2015-06-18       Impact factor: 4.379

5.  Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.

Authors:  Esraa Aly; Willias Masocha
Journal:  IBRO Neurosci Rep       Date:  2021-01-25

6.  BMDExpress: a software tool for the benchmark dose analyses of genomic data.

Authors:  Longlong Yang; Bruce C Allen; Russell S Thomas
Journal:  BMC Genomics       Date:  2007-10-25       Impact factor: 3.969
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.